Christopher J. H. Porter

27.5k citations

311 papers · 21.7k indexed · 8 hit papers · h-index 74

Pharmaceutical Science top 0.01%
- Drug Solubulity and Delivery Systems 86
- Advanced Drug Delivery Systems 34
Biomaterials top 0.2%
Spectroscopy top 0.2%
- Analytical Chemistry and Chromatography 31
- Mass Spectrometry Techniques and Applications 24
Oncology top 0.5%
- Drug Transport and Resistance Mechanisms 76
Analytical Chemistry top 0.2%
Pediatrics, Perinatology and Child Health
- Pharmaceutical studies and practices 32
Molecular Biology
- RNA Interference and Gene Delivery 26
Polymers and Plastics
- Dendrimers and Hyperbranched Polymers 23

Co-authors: William N. Charman Natalie L. Trevaskis Colin W. Pouton Ben J. Boyd Lisa M. Kaminskas Susan A. Charman Hywel D. Williams Glenn A. Edwards
Cited by: Pharmaceutical Science Biomaterials Spectroscopy
Journals: Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (4 papers)Angewandte Chemie International Edition (1 paper)
Partner nations: Australia United States United Kingdom

In The Last Decade

Christopher J. H. Porter

307 papers receiving 21.0k citations

Hit Papers

8 papers align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2018 Nature Nanotechnology
2016 Advanced Drug Delivery Reviews
2015 Nature Reviews Drug Discovery
2013 Pharmacological Reviews
2007 Nature Reviews Drug Discovery
2007 Advanced Drug Delivery Reviews
2007 Advanced Drug Delivery Reviews
1997 Journal of Pharmaceutical Sciences

Peers

Countries citing papers authored by Christopher J. H. Porter

Since Specialization

Citations

This map shows the geographic impact of Christopher J. H. Porter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J. H. Porter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J. H. Porter more than expected).

Fields of papers citing papers by Christopher J. H. Porter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher J. H. Porter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J. H. Porter. The network helps show where Christopher J. H. Porter may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Christopher J. H. Porter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Christopher J. H. Porter Line = papers co-authored together Christopher J. H. Porter links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Optimizing Triglyceride Prodrugs of a Model Immunomodulator: Conjugation through the Phenol of Mycophenolic Acid (MPA) Markedly Promotes Lymphatic Drug Transport Molecular Pharmaceutics ·Luojuan Hu,Tim Quach,Dan Zheng,Nathania J. Leong,Garima Sharma,Shea F. Lim,Daniel K. Bonner,Natalie L. Trevaskis,Jamie S. Simpson,Sifei Han,Christopher J. H. Porter	2025	0
2	Lymphatic Uptake of a Highly Lipophilic Protease Inhibitor Prodrug from a Lipid-Based Formulation is Limited by Instability in the Intestine Journal of Pharmaceutical Sciences ·Yining Xie,Zijun Lu,Ian K. Styles,Sanjeevini Babu Reddiar,Anthony R.J. Phillips,John A. Windsor,Christopher J. H. Porter,Sifei Han,Natalie L. Trevaskis	2024	0
3	Intestinal Lymphatic Biology, Drug Delivery, and Therapeutics: Current Status and Future Directions Pharmacological Reviews ·Sanjeevini Babu Reddiar,Yining Xie,Mohammad Abdallah,Sifei Han,Luojuan Hu,Orlagh M. Feeney,Gracia Gracia,Abel Anshabo,Zijun Lu,Muhammad Asim Farooq,Ian K. Styles,Anthony R.J. Phillips,John A. Windsor,Christopher J. H. Porter,Enyuan Cao,Natalie L. Trevaskis	2024	1
4	Increasing Linker Chain Length and Intestinal Stability Enhances Lymphatic Transport and Lymph Node Exposure of Triglyceride Mimetic Prodrugs of a Model Immunomodulator Mycophenolic Acid Molecular Pharmaceutics ·Sifei Han,Tim Quach,Luojuan Hu,Shea F. Lim,Dan Zheng,Nathania J. Leong,Garima Sharma,Daniel K. Bonner,Jamie S. Simpson,Natalie L. Trevaskis,Christopher J. H. Porter	2023	4
5	Digestion of Lipid-Based Formulations Not Only Mediates Changes to Absorption of Poorly Soluble Drugs Due to Differences in Solubilization But Also Reflects Changes to Thermodynamic Activity and Permeability Molecular Pharmaceutics ·Yusuke Tanaka,Tri‐Hung Nguyen,Estelle J. A. Suys,Christopher J. H. Porter	2021	9
6	A lipid-anchored neurokinin 1 receptor antagonist prolongs pain relief by a three-pronged mechanism of action targeting the receptor at the plasma membrane and in endosomes Journal of Biological Chemistry ·N. Quynh,Priyank A. Shenoy,Tim Quach,Jeffri S. Retamal,Arisbel B. Gondin,Holly R. Yeatman,Luigi Aurelio,Joshua Conner,Daniel P. Poole,Meritxell Canals,Cameron J. Nowell,Bim Graham,Thomas P. Davis,Stephen J. Briddon,Stephen J. Hill,Christopher J. H. Porter,Nigel W. Bunnett,Michelle L. Halls,Nicholas A. Veldhuis	2021	15
7	Molecular Dynamics Simulations and Experimental Results Provide Insight into Clinical Performance Differences between Sandimmune® and Neoral® Lipid-Based Formulations Pharmaceutical Research ·Dallas B. Warren,Shadabul Haque,Mitchell P. McInerney,Karen Corbett,Endri Kastrati,Leigh Ford,Hywel D. Williams,Vincent Jannin,Hassan Benameur,Christopher J. H. Porter,David K. Chalmers,Colin W. Pouton	2021	6
8	High-Density Lipoprotein Composition Influences Lymphatic Transport after Subcutaneous Administration Molecular Pharmaceutics ·Gracia Gracia,Enyuan Cao,Orlagh M. Feeney,Angus P. R. Johnston,Christopher J. H. Porter,Natalie L. Trevaskis	2020	25
9	Lymphatic Uptake of Liposomes after Intraperitoneal Administration Primarily Occurs via the Diaphragmatic Lymphatics and is Dependent on Liposome Surface Properties Molecular Pharmaceutics ·Given Lee,Sifei Han,Iasmin Inocencio,Enyuan Cao,Jiwon Hong,Anthony R.J. Phillips,John A. Windsor,Christopher J. H. Porter,Natalie L. Trevaskis	2019	34
10	A ligand-induced structural change in fatty acid–binding protein 1 is associated with potentiation of peroxisome proliferator–activated receptor α agonists Journal of Biological Chemistry ·Rahul Patil,Biswaranjan Mohanty,Bonan Liu,Indu R. Chandrashekaran,Stephen J. Headey,M.L. Williams,Craig S. Clements,O.V. Ilyichova,B.C. Doak,Patrick Genissel,Richard Weaver,Laurent Vuillard,Michelle L. Halls,Christopher J. H. Porter,M.J. Scanlon	2019	19
11	Engineering Biocoatings To Prolong Drug Release from Supraparticles Biomacromolecules ·Yutian Ma,Christina Cortez‐Jugo,Jianhua Li,Zhixing Lin,Rachael T. Richardson,Yiyuan Han,Jiajing Zhou,Mattias Björnmalm,Orlagh M. Feeney,Qi‐Zhi Zhong,Christopher J. H. Porter,Andrew K. Wise,Frank Caruso	2019	27
12	Minimum information reporting in bio–nano experimental literaturebreakdown → Nature Nanotechnology ·Matthew Faria,Mattias Björnmalm,Kristofer J. Thurecht,Stephen J. Kent,Robert G. Parton,Maria Kavallaris,Angus P. R. Johnston,J. Justin Gooding,Simon R. Corrie,Ben J. Boyd,Pall Thordarson,Andrew K. Whittaker,Molly M. Stevens,Clive A. Prestidge,Christopher J. H. Porter,Wolfgang J. Parak,Thomas P. Davis,Edmund J. Crampin,Frank Caruso	2018	482
13	Enhancing the Oral Absorption of Kinase Inhibitors Using Lipophilic Salts and Lipid-Based Formulations Molecular Pharmaceutics ·Hywel D. Williams,Leigh Ford,Sifei Han,Kristian J. Tangso,Shea F. Lim,David M. Shackleford,D. Vodak,Hassan Benameur,Colin W. Pouton,Peter J. Scammells,Christopher J. H. Porter	2018	46
14	Gel-Mediated Electrospray Assembly of Silica Supraparticles for Sustained Drug Delivery ACS Applied Materials & Interfaces ·Yutian Ma,Mattias Björnmalm,Andrew K. Wise,Christina Cortez‐Jugo,Eve Revalor,Yi Ju,Orlagh M. Feeney,Rachael T. Richardson,Eric Hanssen,Robert K. Shepherd,Christopher J. H. Porter,Frank Caruso	2018	42
15	Ionic Liquid Forms of Weakly Acidic Drugs in Oral Lipid Formulations: Preparation, Characterization, in Vitro Digestion, and in Vivo Absorption Studies Molecular Pharmaceutics ·Yasemin Sahbaz,Tri‐Hung Nguyen,Leigh Ford,Claire L. McEvoy,Hywel D. Williams,Peter J. Scammells,Christopher J. H. Porter	2017	51
16	Computational Models of the Intestinal Environment. 3. The Impact of Cholesterol Content and pH on Mixed Micelle Colloids Molecular Pharmaceutics ·Estelle J. A. Suys,Dallas B. Warren,Christopher J. H. Porter,Hassan Benameur,Colin W. Pouton,David K. Chalmers	2017	25
17	Glyceride‐Mimetic Prodrugs Incorporating Self‐Immolative Spacers Promote Lymphatic Transport, Avoid First‐Pass Metabolism, and Enhance Oral Bioavailability Angewandte Chemie International Edition ·Luojuan Hu,Tim Quach,Sifei Han,Shea F. Lim,Preeti Yadav,Danielle Senyschyn,Natalie L. Trevaskis,Jamie S. Simpson,Christopher J. H. Porter	2016	55
18	Glyceride‐Mimetic Prodrugs Incorporating Self‐Immolative Spacers Promote Lymphatic Transport, Avoid First‐Pass Metabolism, and Enhance Oral Bioavailability Angewandte Chemie ·Luojuan Hu,Tim Quach,Sifei Han,Shea F. Lim,Preeti Yadav,Danielle Senyschyn,Natalie L. Trevaskis,Jamie S. Simpson,Christopher J. H. Porter	2016	7
19	An evaluation of the relative roles of the unstirred water layer and receptor sink in limiting the in-vitro intestinal permeability of drug compounds of varying lipophilicity Journal of Pharmacy and Pharmacology ·Kasiram Katneni,Susan A. Charman,Christopher J. H. Porter	2008	17
20	Cationic Poly- l -lysine Dendrimers: Pharmacokinetics, Biodistribution, and Evidence for Metabolism and Bioresorption after Intravenous Administration to Rats Molecular Pharmaceutics ·Ben J. Boyd,Lisa M. Kaminskas,Peter Karellas,Guy Y. Krippner,Romina Lessene,Christopher J. H. Porter	2006	118

About Christopher J. H. Porter

Christopher J. H. Porter is a scholar working on Pharmaceutical Science, Oncology and Spectroscopy, having authored 311 papers that have together received 21.7k indexed citations. Recurring topics across this work include Drug Solubulity and Delivery Systems (86 papers), Drug Transport and Resistance Mechanisms (76 papers), Advanced Drug Delivery Systems (34 papers), Pharmaceutical studies and practices (32 papers), Analytical Chemistry and Chromatography (31 papers), RNA Interference and Gene Delivery (26 papers), Mass Spectrometry Techniques and Applications (24 papers) and Dendrimers and Hyperbranched Polymers (23 papers). The work is most often cited by research in Pharmaceutical Science (9.9k citations), Biomaterials (2.6k citations) and Spectroscopy (2.6k citations). Christopher J. H. Porter has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include William N. Charman, Natalie L. Trevaskis, Colin W. Pouton, Ben J. Boyd, Lisa M. Kaminskas, Susan A. Charman, Hywel D. Williams, Glenn A. Edwards, Ann Marie Kaukonen and Hassan Benameur. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Angewandte Chemie International Edition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact